We identified that OR11H1‐A63 accelerated inflammatory factor release and BRB breakdown, suggesting that OR11H1‐A63 might be involved in the development of VKH disease, and could be considered a target for anti‐inflammatory treatments. Here, OR11H1 is linked to Vogt-Koyanagi-Harada disease.